51. 全身性強皮症 Scleroderma Clinical trials / Disease details


臨床試験数 : 523 薬物数 : 617 - (DrugBank : 156) / 標的遺伝子数 : 113 - 標的パスウェイ数 : 214

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00498615
(ClinicalTrials.gov)
April 20076/7/2007A Rho-kinase Inhibitor (Fasudil) in the Treatment of Raynaud's PhenomenonEfficacy, Tolerability and Biology of a Rho-kinase Inhibitor (Fasudil) in the Treatment of Raynaud's PhenomenonRaynaud;SclerodermaDrug: FasudilJohns Hopkins UniversityNULLCompleted18 Years80 YearsAll17Phase 3United States